Centessa Pharmaceuticals plc (CNTA) ADS EACH REPR 1 ORD SHS

Sell:$39.59Buy:$39.61Price unchangedNo change

NASDAQ:Price increased1.96%
Market closed |
Prices delayed by at least 15 minutes
Sell:$39.59
Buy:$39.61
Change:Price unchangedNo change
Deal now
Market closed |
Prices delayed by at least 15 minutes
Sell:$39.59
Buy:$39.61
Change:Price unchangedNo change
Market closed |
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open$39.58
Previous close$39.57
Market cap$6.12bn
P/E ratio-
Volume303,888
Dividend yield0.00%
EMS-

Company information

Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company. The Company is developing a new class of potential therapies within its orexin receptor 2 (OX2R) agonist program for the treatment of excessive ...

  • LocationUnited Kingdom
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue0.00
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.